Compare BFRI & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BFRI | AMS |
|---|---|---|
| Founded | 1997 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 10.0M |
| IPO Year | 2021 | 1995 |
| Metric | BFRI | AMS |
|---|---|---|
| Price | $0.82 | $1.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 168.1K | 7.8K |
| Earning Date | 11-16-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,705,000.00 | $19,714,000.00 |
| Revenue This Year | $10.65 | $16.37 |
| Revenue Next Year | $15.88 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 11.75 | 0.81 |
| 52 Week Low | $0.57 | $1.20 |
| 52 Week High | $1.66 | $2.39 |
| Indicator | BFRI | AMS |
|---|---|---|
| Relative Strength Index (RSI) | 39.08 | 30.16 |
| Support Level | $0.77 | N/A |
| Resistance Level | $0.96 | $1.52 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 23.31 | 14.18 |
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. Company operates in two segments, the medical equipment leasing segment where a contract exists between the hospital and the Company and the direct patient services segment, where a contract exists between the Company facilities and the individual treated at the facility. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates it's key revenue from the domestic market.